Recommandé
Contenu connexe
Plus de Rose088
Plus de Rose088 (20)
Dernier
Dernier (20)
Alnylam pharmaceuticals, inc – product pipeline review – 2012
- 1. Aarkstore.com announces, The Latest market research report is available in its vast collection: Alnylam Pharmaceuticals, Inc – Product Pipeline Review – 2012 You can also request for sample page of above mention reports on sample@aarkstore.com Summary Global Market Direct’s pharmaceuticals report, “Alnylam Pharmaceuticals, Inc - Product Pipeline Review - 2012” provides data on the Alnylam Pharmaceuticals, Inc’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built using data and information sourced from Global Markets Direct’s proprietary databases, Alnylam Pharmaceuticals, Inc’s corporate website, SEC filings, investor presentations and featured press releases, both from Alnylam Pharmaceuticals, Inc and industry-specific third party sources, put together by Global Markets Direct’s team. Scope
- 2. - Alnylam Pharmaceuticals, Inc - Brief Alnylam Pharmaceuticals, Inc overview including business description, key information and facts, and its locations and subsidiaries. - Review of current pipeline of Alnylam Pharmaceuticals, Inc human therapeutic division. - Overview of pipeline therapeutics across various therapy areas. - Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe. Table of contents: List of Tables 7 List of Figures 9 Alnylam Pharmaceuticals, Inc Snapshot 10 Alnylam Pharmaceuticals, Inc Overview 10 Key Information 10 Key Facts 10 Arena Pharmaceuticals, Inc. – Research and Development Overview 11 Key Therapeutic Areas 11 Arena Pharmaceuticals, Inc. – Pipeline Review 14 Pipeline Products by Stage of Development 14 Pipeline Products – Monotherapy 15 Arena Pharmaceuticals, Inc. – Pipeline Products Glance 16 Arena Pharmaceuticals, Inc. Clinical Stage Pipeline Products 16 Phase II Products/Combination Treatment Modalities 16 Phase I Products/Combination Treatment Modalities 17 Arena Pharmaceuticals, Inc. – Early Stage Pipeline Products 18 Pre-Clinical Products/Combination Treatment Modalities 18 Discovery Products/Combination Treatment Modalities 19 Arena Pharmaceuticals, Inc. – Drug Profiles 20 ALN-APC Program 20 Product Description 20 Mechanism of Action 20 R&D Progress 20 ALN-HPN 21 Product Description 21 Mechanism of Action 21
- 3. R&D Progress 21 ALN-HTT 22 Product Description 22 Mechanism of Action 22 R&D Progress 22 ALN-PCS 23 Product Description 23 Mechanism of Action 23 List of Figures List of Tables are also include. For more related Reports Plz follow The link: Product Pipeline Review – 2012 http://www.aarkstore.com/search/viewresults.asp?search=Product Pipeline Review – 2012&PubId=&pagenum=1 Alexion Pharmaceuticals, Inc. – Product Pipeline Review – 2012 Alnylam Pharmaceuticals, Inc – Product Pipeline Review – 2012 Ampio Pharmaceuticals, Inc. – Product Pipeline Review – 2012 Arena Pharmaceuticals, Inc. – Product Pipeline Review – 2012 ArQule, Inc. – Product Pipeline Review – 2012 Baxter International Inc. – Product Pipeline Review – 2012
- 4. BioCryst Pharmaceuticals, Inc. – Product Pipeline Review – 2012 Columbia Laboratories Inc. – Product Pipeline Review – 2012 Corcept Therapeutics Incorporated – Product Pipeline Review – 2012 Curis, Inc. – Product Pipeline Review – 2012 Search More Reports Related to This Category : Pharmaceuticals and Healthcare http://www.aarkstore.com/search/viewresults.asp?search=Pharmaceuticals and Healthcare&PubId=&pagenum=1 For More details Plz do contact : Aarkstore Enterprise Lavanya Phone:08149852585 Email: enquiry@aarkstore.com